Trilipix
Links shared publicly online about this topic
SAFETY ALERT: Trilipix Label Change - MPR
empr.com — “The FDA has notified healthcare professionals that the cholesterol-lowering medicine Trilipix (fenofibric acid; Abbott) may not lower a patient's risk of having a heart attack or stroke.” View full resource at empr.com
Most Recently Shared on November 9, 2011 at 5:30 pm By:
FDA Announces That Trilipix May Not Lower Risk of Heart Attack or Stroke http://t.co/9Y9TrImZ #Cardiovascular #Stroke
Skitch.com > darrylohrt > trilipix
skitch.com — “Skitch Web” View full resource at skitch.com
Most Recently Shared on April 5, 2010 at 12:02 pm By:
Dr. John Grohol Doctor, Psychologist, and PsyD
Thank the FDA for this- pharma has no choice. @darrylohrt: Yikes . When did pharma banner ads become this craptastic? http://bit.ly/ajAY6W
Companies ask FDA to approve Crestor-Trilipix combo pill
theheart.org — “If the agency agrees, the companies will market the new drug as Certriad.” View full resource at theheart.org
Most Recently Shared on June 8, 2009 at 8:59 pm By:
heartwire: AstraZeneca, Abbott ask the FDA to approve Crestor-Trilipix combo pill http://bit.ly/qSacl
Trilipix With Statin No Better Than Statin Alone? FDA Panel Meets This Week
medicalnewstoday.com — “Abbot's blockbuster cholesterol drug, Trilipix (fenofibrate), which is taken in combination with a statin was found to be no better at reducing heart attack risk than taking the statin alone, in a” View full resource at medicalnewstoday.com
Most Recently Shared on May 18, 2011 at 1:05 am By:
MNT Cholesterol News Health News
Trilipix With Statin No Better Than Statin Alone? FDA Panel Meets This Week http://mnt.to/3VZf #cholesterol
FDA panel to review Abbott cholesterol drug Trilipix - chicagotribune.com
chicagotribune.com — “A Food and Drug Administration panel will discuss the safety and effectiveness of Abbott Laboratories' (ABT) cholesterol drug Trilipix next month, the agency said Monday.” View full resource at chicagotribune.com
Most Recently Shared on April 26, 2011 at 1:20 pm By:
James Underberg Internist, Physician, and Doctor
FDA panel to review Abbott cholesterol drug Trilipix - chicagotribune.com http://t.co/6aQaHB6
Trilipix With Statin No Better Than Statin Alone? FDA Panel Meets This Week
medicalnewstoday.com — “Abbott's blockbuster cholesterol drug, Trilipix (fenofibrate), which is taken in combination with a statin was found to be no better at reducing heart attack risk than taking the statin alone, in” View full resource at medicalnewstoday.com
Most Recently Shared on May 18, 2011 at 2:28 am By:
HDCN: FDA advisory panel will convene to reconsider approval of fenofibrate http://bit.ly/mdJ4EN
Trilipix Not Found to Reduce Risk of Coronary Events --Doctors Lounge
doctorslounge.com — “Trilipix Not Found to Reduce Risk of Coronary Events --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on November 10, 2011 at 1:05 am By:
Trilipix Not Found to Reduce Risk of Coronary Events http://t.co/pg69sqkm #Health #Medicine
FDA panel to weigh revoking key use of Trilipix - USATODAY.com
yourlife.usatoday.com — “A panel of advisers to the Food and Drug Administration will consider this week whether to revoke a key indication from Abbott's blockbuster cholesterol drug Trilipix.” View full resource at yourlife.usatoday.com
Most Recently Shared on May 17, 2011 at 5:07 pm By:
FDA panel to weigh revoking key use of Trilipix http://usat.ly/lV7WeK
Impax Laboratories initiates challenge of patent over generic TRILIPIX
news-medical.net — “Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patent listed by Abbott Laboratories and Fournier Laboratories Ireland Ltd. in connection with its TRILIPIX® (choline fenofibrate) delayed-release capsules, 135 mg and 45 mg.” View full resource at news-medical.net
Most Recently Shared on March 15, 2010 at 4:53 pm By:
Impax Laboratories initiates challenge of patent over generic TRILIPIX: Impax Laboratories, Inc. today confirms th... http://bit.ly/cm4ZNJ
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 9:44 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
http://ow.ly/4X9To TriLipix + Simvastatin no better than Simvastatin alone for Cardiovascular diseases
Watson Pharmaceuticals sued in connection with filing ANDA for generic equivalent of Trilipix
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, has been sued by Abbott Laboratories and Fournier Laboratories Ireland Ltd. in connection with the filing of Watson's Abbreviated New Drug Application for choline fenofibrate delayed-release capsules in the 45 mg and 135 mg strengths.” View full resource at news-medical.net
Most Recently Shared on May 3, 2010 at 11:07 am By:
Medicare News: Watson Pharmaceuticals sued in connection with filing ANDA for generic equivalent of Trilipix: Wats... http://bit.ly/cBYurJ
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 12:29 pm By:
A study has suggested thatTriLipix, does not protect against heart attacks or strokes better than a generic medicine http://nyti.ms/mLoXWX
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 6:43 am By:
Drug Study a Setback for Abbott http://bit.ly/k3blFU
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 4:26 am By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Drug Study a Setback for Abbott - The study showed no significant reduction in heart attacks, strokes and cardiac de... http://ow.ly/1cJ1QB
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 3:50 am By:
Studies show med does protect against heart attack or stroke...http://nyti.ms/jAoP6Q
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Dr. John Grohol
CEO & Founder of Psych Central.com
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement
